These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9665956)

  • 1. Concentrations of circulating beta-chemokines do not correlate with viral load in human immunodeficiency virus-infected individuals.
    Kakkanaiah VN; Ojo-Amaize EA; Peter JB
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):499-502. PubMed ID: 9665956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
    De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K; Bentsman G; Chess L; Volsky DJ
    J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
    Ye P; Kazanjian P; Kunkel SL; Kirschner DE
    J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous levels of C-C chemokines MIP-1alpha, MIP-1beta, and RANTES do not reflect the disease course in HIV-seropositive individuals.
    Kreuzer KA; Rockstroh JK; Kupfer B; Spengler U
    Int J Clin Lab Res; 2000; 30(4):163-8. PubMed ID: 11289705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection.
    Weiss L; Si-Mohamed A; Giral P; Castiel P; Ledur A; Blondin C; Kazatchkine MD; Haeffner-Cavaillon N
    J Infect Dis; 1997 Dec; 176(6):1621-4. PubMed ID: 9395378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir.
    Bisset LR; Rothen M; Joller-Jemelka HI; Dubs RW; Grob PJ; Opravil M
    AIDS; 1997 Mar; 11(4):485-91. PubMed ID: 9084796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
    Casoli C; Vicenzi E; Cimarelli A; Magnani G; Ciancianaini P; Cattaneo E; Dall'Aglio P; Poli G; Bertazzoni U
    Blood; 2000 May; 95(9):2760-9. PubMed ID: 10779418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals.
    Mikawa AY; Tagliavini SA; Costa PI
    Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.
    Lewis MJ; Gautier VW; Wang XP; Kaplan MH; Hall WW
    J Immunol; 2000 Oct; 165(7):4127-32. PubMed ID: 11034425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
    J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.
    Leith JG; Copeland KF; McKay PJ; Richards CD; Rosenthal KL
    AIDS; 1997 Apr; 11(5):575-80. PubMed ID: 9108938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific production of RANTES, macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta in vitro is a correlate of reduced human immunodeficiency virus burden in vivo.
    Ferbas J; Giorgi JV; Amini S; Grovit-Ferbas K; Wiley DJ; Detels R; Plaeger S
    J Infect Dis; 2000 Oct; 182(4):1247-50. PubMed ID: 10979927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.
    Kinter AL; Ostrowski M; Goletti D; Oliva A; Weissman D; Gantt K; Hardy E; Jackson R; Ehler L; Fauci AS
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14076-81. PubMed ID: 8943063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
    Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
    Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
    Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.